Individuals with a history of heart attack, multi-vessel bypass, or high risk for a second event may benefit from aggressive therapies like statins and PCSK9 inhibitors.

“You know, you've treated people in the hospital who have had heart attacks, have had their chest cracked open with multi-vessel bypass, you're just trying to prevent, you know, the second event, you know, you're throwing the kitchen sink at these individuals just to try to put out the fires. You know, those individuals will do better on those type of therapies”